{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Schering", "item": "https://www.patentleaderboard.com/company/schering"}, {"@type": "ListItem", "position": 3, "name": "Harry Davis", "item": "https://www.patentleaderboard.com/inventor/fl:ha_ln:davis-18"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
HD

Harry Davis — 14 Patents

SCSchering: 13 patents #214 of 2,442Top 9%
Merck: 1 patents #5,440 of 9,382Top 60%
Berkeley Heights, NJ: #132 of 1,035 inventorsTop 15%
New Jersey: #6,230 of 69,400 inventorsTop 9%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Harry Davis has been granted 14 US patents while listed as an inventor at Schering. The first was granted in 1993 and the most recent in August 2021. Harry Davis ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Harry Davis in Berkeley Heights, NJ, US.

Patents per Year

Patents granted per year, 1993 to 2021Bar chart with a peak of 5 patents in 2006.peak 51993: 1 patents19931997: 1 patents19971998: 1 patents19982003: 2 patents20032005: 1 patents20052006: 5 patents20062008: 1 patents20082010: 1 patents20102021: 1 patents2021

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11077092 Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor Hong-Ping Guan, Jose M. Castro-Perez, Samuel E. Engel, Douglas G. Johns, Songnian Lin +5 more 2021-08-03 $173,929,000
7723020 Use of azetidinone compounds Scott W. Altmann, Duane A. Burnett, Michael Graziano, Maureen Laverty, Xiaorui Yao 2010-05-25
7417039 Use of substituted azetidinone compounds for the treatment of sitosterolemia 2008-08-26 $184,410,000
7144696 Use of azetidinone compounds Scott W. Altmann, Duane A. Burnett, Michael Graziano, Maureen Laverty, Xiaorui Yao 2006-12-05 $148,537,000
7132415 Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors 2006-11-07 $64,122,000
7071181 Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors Teddy Kosoglou, Gilles Picard, Rudyard Ress, John T. Strony, Enrico Veltri 2006-07-04
7053080 Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors Rudyard Ress, John T. Strony, Enrico Veltri 2006-05-30 $33,879,000
6982251 Substituted 2-azetidinones useful as hypocholesterolemic agents Anima Ghosal, Shmuel Zbaida, Swapan Chowdhury, Robert Iannucci, Wenqing Feng +2 more 2006-01-03 $72,918,000
6933107 Use of azetidinone compounds Scott W. Altmann, Duane A. Burnett, Michael Graziano, Maureen Laverty, Xiaorui Yao 2005-08-23 $77,246,000
6632933 Use of azetidinone compounds Scott W. Altmann, Duane A. Burnett, Michael Graziano, Maureen Laverty, Xiaorui Yao 2003-10-14 $44,282,000
6593078 Use of azetidinone compounds Scott W. Altmann, Duane A. Burnett, Michael Graziano, Maureen Laverty, Xiaorui Yao 2003-07-15 $229,227,000
5756470 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents Nathan Yumibe, Kevin Alton, Margaret van Heek, Wayne Vaccaro 1998-05-26 $100,669,000
5661145 Combination of a cholesterol biosynthesis inhibitor and a .beta.-lactam cholesterol absorption inhibitor 1997-08-26 $46,075,000
5238950 Inhibitors of platelet-derived growth factor John W. Clader, Deborra Mullins, Stuart B. Rosenblum, Jay Weinstein 1993-08-24 $24,880,000